Literature DB >> 26311078

Bone marrow trephine biopsy involvement by lymphoma: pattern of involvement and concordance with flow cytometry, in 10 years from a single institution.

M A Cabezas-Quintario1, P Gomez2, V Yuste-Del Pozo2, A L Valencia-Mesa2, G Sosa2, P Ricard3, A I Hijas-Gómez4, F Pinedo2, M Arguelles2.   

Abstract

PURPOSE: To evaluate the features of bone marrow (BM) biopsy involvement by lymphoma, pattern of infiltration, morphological analysis and flow cytometry were reviewed at all lymphoma patients over a period of 10 years. METHODS/PATIENTS: 413 cases were included in the study if BM biopsy slides were available. Only 356 patients had both BM trephine biopsy and flow cytometry.
RESULTS: The most frequent subtype was diffuse large B cell (31.2%), followed by follicular lymphoma (18.9%). The predominant pattern was mixed (nodular-interstitial) (9.2%). Morphological marrow infiltration was found in 138 cases, and flow cytometry identified 117 cases with BM involvement. A concordance between the two methods was detected in 305 cases (85.7%). There was discordance in 51 cases (14.3%): morphology positive/FC negative in 33 cases and morphology negative/FC positive in 18.
CONCLUSIONS: Flow cytometry is slightly more useful in detecting involvement when the BM is affected, but this finding is not conclusive.

Entities:  

Keywords:  Bone marrow; Discordance; Flow cytometry; Lymphoma; Pattern involvement

Mesh:

Year:  2015        PMID: 26311078     DOI: 10.1007/s12094-015-1393-9

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  10 in total

1.  Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens.

Authors:  Daniel A Arber; Tracy I George
Journal:  Am J Surg Pathol       Date:  2005-12       Impact factor: 6.394

2.  Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.

Authors:  C Palacio; G Acebedo; M Navarrete; C Ruiz-Marcellán; C Sanchez; A Blanco; A López
Journal:  Haematologica       Date:  2001-09       Impact factor: 9.941

Review 3.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

4.  Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings.

Authors:  Vishakha Sovani; Caroline Harvey; Andrew P Haynes; Andrew K McMillan; David M Clark; Simon R O'Connor
Journal:  J Clin Pathol       Date:  2013-12-10       Impact factor: 3.411

5.  Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL).

Authors:  G Perea; A Altés; M Bellido; A Aventín; R Bordes; R Ayats; A F Remacha; I Espinosa; J Briones; J Sierra; J F Nomdedéu
Journal:  Histopathology       Date:  2004-09       Impact factor: 5.087

6.  Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma: a study from the Groupe d'Etude des Lymphomes Folliculaires.

Authors:  Danielle Canioni; Pauline Brice; Eric Lepage; Myrna Chababi; Véronique Meignin; Bruno Salles; Luc Xerri; Pierre-Yves Péaud; Philippe Rousselot; Michel Peuchmaur; Philippe Solal-Céligny; Nicole Brousse
Journal:  Br J Haematol       Date:  2004-08       Impact factor: 6.998

Review 7.  Comparison of the efficacies of closed trephine needle biopsy, aspirated paraffin-embedded clot section, and smear preparation in the diagnosis of bone-marrow involvement by lymphoma.

Authors:  J W Dee; M Valdivieso; B Drewinko
Journal:  Am J Clin Pathol       Date:  1976-02       Impact factor: 2.493

8.  Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

Authors:  Massimo Federico; Monica Bellei; Luigi Marcheselli; Stefano Luminari; Armando Lopez-Guillermo; Umberto Vitolo; Barbara Pro; Stefano Pileri; Alessandro Pulsoni; Pierre Soubeyran; Sergio Cortelazzo; Giovanni Martinelli; Maurizio Martelli; Luigi Rigacci; Luca Arcaini; Francesco Di Raimondo; Francesco Merli; Elena Sabattini; Peter McLaughlin; Philippe Solal-Céligny
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

9.  Prognostic value of bone marrow involvement by clonal immunoglobulin gene rearrangements in follicular lymphoma.

Authors:  Ellen Berget; Lars Helgeland; Knut Liseth; Turid Løkeland; Anders Molven; Olav Karsten Vintermyr
Journal:  J Clin Pathol       Date:  2014-09-18       Impact factor: 3.411

10.  Bone marrow flow cytometry in staging of patients with B-cell non-Hodgkin lymphoma.

Authors:  Borahm Kim; Seung-Tae Lee; Hee-Jin Kim; Sun Hee Kim
Journal:  Ann Lab Med       Date:  2015-02-12       Impact factor: 3.464

  10 in total
  3 in total

1.  DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement.

Authors:  Junhua Mai; Xin Li; Guodong Zhang; Yi Huang; Rong Xu; Qi Shen; Ganesh L Lokesh; Varatharasa Thiviyanathan; Lingxiao Chen; Haoran Liu; Youli Zu; Xiaojing Ma; David E Volk; David G Gorenstein; Mauro Ferrari; Haifa Shen
Journal:  Mol Pharm       Date:  2018-03-26       Impact factor: 4.939

2.  How useful is bone marrow study as an initial investigative tool without lymph node biopsy in malignant lymphoma?: Eleven years of experience at a single institution.

Authors:  Woo-Jae Kwoun; Jeong-Yeal Ahn; Pil-Whan Park; Yiel-Hea Seo; Kyung-Hee Kim; Ja Young Seo; Hwan Tae Lee; Kuai-Han Yoo
Journal:  J Clin Lab Anal       Date:  2019-02-06       Impact factor: 2.352

3.  Increase of CD3+CD7- T cells in bone marrow predicts invasion in patients with T-cell non-Hodgkin's lymphoma.

Authors:  Ziyang Huang; Binbin Chen; Yixin Ling; Yangya Pan; Songfu Jiang; Shenghui Zhang; Kang Yu; Yixiang Han
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.